Company
JumpstartMD
No comparable monthly price verified. Dated notes below explain advertised amounts, billing periods and remaining uncertainty.
Published by Treatment Registry · Latest research
- 8 programs
- 6 identified molecules
- 8 readings
Read from jumpstartmd.com; latest program check October 2026. Individual programs and sources may have earlier verification dates.
Go to JumpstartMD
Visit JumpstartMD
We earn nothing from this link. It opens JumpstartMD's website without a paid referral.
Terms
- Pharmacy
Not disclosed
Across recorded programs · Evidence: October 2026
- Membership
Required, amount not published. Medication is prescribed as part of membership, and medication costs are not included in membership fees; no ongoing care fee is published in the reviewed public pages. https://jumpstartmd.com/faq/ https://jumpstartmd.com/insurance/
Across recorded programs · Evidence: October 2026
- Consultation fee
Not disclosed
Across recorded programs · Evidence: October 2026
- States
California
Across recorded programs · Evidence: October 2026
Programs
More columns to the right? Scroll across the table to see all details.
| Entry | Program | Form | Recorded price with its payment basis | Link |
|---|---|---|---|---|
| EntryTR-1089 | ProgramBrand semaglutide | FormInjection · device not recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1090 | ProgramBrand semaglutide | FormOral tablet | Recorded priceNo comparable monthly price | Record |
| EntryTR-1091 | ProgramBrand semaglutide | FormOral · dosage form not recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1092 | ProgramBrand tirzepatide | FormInjection · device not recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1093 | ProgramBrand liraglutide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1094 | ProgramDulaglutide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1095 | ProgramBrand orforglipron | FormOral · dosage form not recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1097 | ProgramBrand exenatide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
Notes
Pricing details, service terms and questions to confirm before enrolling.
October 2026
- 1. JumpstartMD lists clinician-selected prescription options as part of its supervised membership. The public catalog names Ozempic, Wegovy, oral Wegovy, Rybelsus, Zepbound, Mounjaro, Saxenda and Trulicity; the dedicated Foundayo page explicitly says its clinicians prescribe orforglipron. Ingredient overview pages are not evidence of a separate compounded program. https://jumpstartmd.com/weight-loss-medications/ https://jumpstartmd.com/weight-loss-medication-foundayo/
- 2. Medication costs are not included in membership fees. The public pages advertise a limited-time $99 getting-started offer, previously $379, without establishing the ongoing membership amount or complete first invoice. Retail estimates and manufacturer savings as low as $25 are not JumpstartMD drug prices or universally available invoices. https://jumpstartmd.com/faq/ https://jumpstartmd.com/insurance/ https://jumpstartmd.com/weight-loss-medication-mounjaro/ https://jumpstartmd.com/weight-loss-medication-zepbound/
Show 10 more notesHide 10 more notes
- 3. The service describes California clinics and online appointments for members throughout California. Treatment remains subject to clinical eligibility. Quest is a laboratory partner, not a dispensing pharmacy. Patients can use a pharmacy of choice or an unnamed partner pharmacy; no individual dispenser is assigned. https://jumpstartmd.com/locations/ https://jumpstartmd.com/online-care/ https://jumpstartmd.com/faq/
- 4. The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medication-wegovy/ https://jumpstartmd.com/weight-loss-medication-ozempic/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
- 5. The practice offers in-person and online clinician appointments, laboratory review and health coaching. The reviewed public pages do not establish one universal mandatory video versus asynchronous prescribing modality. Website Terms of Use are not a published patient medication-refund or membership-renewal policy. https://jumpstartmd.com/online-care/ https://jumpstartmd.com/terms-of-use/
- 6. The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medication-rybelsus/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
- 7. The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medication-oral-wegovy/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
- 8. The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medication-zepbound/ https://jumpstartmd.com/weight-loss-medication-mounjaro/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
- 9. The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medications/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
- 10. The medication FAQ additionally names Victoza alongside Saxenda as liraglutide options; neither page establishes a dispensing device for this program. https://jumpstartmd.com/faq/
- 11. The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medication-foundayo/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
- 12. The actual opened GLP-1 medication tab explicitly lists Byetta (active ingredient exenatide) among options the practice may prescribe. Its weekly-dosing text conflicts with current federal Byetta labeling, which describes twice-daily subcutaneous dosing and a type 2 diabetes indication. The named catalog offering is retained, but no provider device, dose, frequency or weight-loss approval is asserted. https://jumpstartmd.com/weight-loss-medications/ https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d03c03-ebf7-418d-88a8-533eabd2ee4f
Understand the terms
- Required membership fees
See how a separate membership changes the amount you pay.
- Checking state availability
Understand the difference between published coverage and individual eligibility.
Before you act
Cite this
Treatment Registry. (2026). JumpstartMD: recorded programs and prices. Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/jumpstartmd